Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ASCL2 |
| Upstream (Parents) |
|---|
| (<<) SATB2 → ASCL2 |
| (<<) CDX2 → ASCL2 |
| (<<) SOX4 → ASCL2 |
| (<<) HOXB9 → ASCL2 |
| (<<) OVOL1 → ASCL2 |
| (<<) NR5A2 → ASCL2 |
| (<<) GRHL2 → ASCL2 |
| (<<) MNX1 → ASCL2 |
| (<<) BACH2 → ASCL2 |
| (<<) NR3C1 → ASCL2 |
| (<<) ARID3A → ASCL2 |
| (<<) PLAGL2 → ASCL2 |
| (<<) TCF7 → ASCL2 |
| Downstream (Children) |
|---|
| ASCL2 → SLC26A3 (>>) |
| ASCL2 → HOXD11 (>>) |
| ASCL2 → PITX2 (>>) |
| ASCL2 → NRL (>>) |
| ASCL2 → MTA2 (>>) |
| ASCL2 → PDX1 (>>) |
| ASCL2 → NR6A1 (>>) |
| ASCL2 → CBFA2T3 (>>) |
| ASCL2 → ZNF155 (>>) |
| ASCL2 → HEYL (>>) |
| ASCL2 → CBFA2T2 (>>) |
| ASCL2 → ATF6B (>>) |
| ASCL2 → CBL (>>) |
| ASCL2 → ETS2 (>>) |
| ASCL2 → STRN3 (>>) |
